- Home
- CRMD vs KURA Comparison
CRMD vs KURA Comparison
Compare CRMD & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRMD | KURA |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 561.8M | 744.0M |
| IPO Year | 2009 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CRMD | KURA |
|---|---|---|
| Price | $6.45 | $8.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | $14.67 | ★ $26.63 |
| AVG Volume (30 Days) | 1.4M | ★ 1.6M |
| Earning Date | 06-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 780.00 | N/A |
| EPS | ★ 2.04 | N/A |
| Revenue | ★ $311,709,000.00 | $67,482,000.00 |
| Revenue This Year | $1.10 | $124.03 |
| Revenue Next Year | N/A | $28.63 |
| P/E Ratio | $3.14 | ★ N/A |
| Revenue Growth | ★ 617.03 | 25.24 |
| 52 Week Low | $5.60 | $5.41 |
| 52 Week High | $17.43 | $12.49 |
Technical Indicators
Market Signals| Indicator | CRMD | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 36.81 | 48.10 |
| Support Level | $6.13 | $7.99 |
| Resistance Level | $7.44 | $10.50 |
| Average True Range (ATR) | 0.30 | 0.41 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 22.81 | 45.83 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.